BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20334485)

  • 1. Fetal and newborn adrenocortical tumors.
    Isaacs H
    Fetal Pediatr Pathol; 2010 Jan; 29(2):99-107. PubMed ID: 20334485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of adrenocortical tumors in children.
    Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
    J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.
    Michalkiewicz E; Sandrini R; Figueiredo B; Miranda EC; Caran E; Oliveira-Filho AG; Marques R; Pianovski MA; Lacerda L; Cristofani LM; Jenkins J; Rodriguez-Galindo C; Ribeiro RC
    J Clin Oncol; 2004 Mar; 22(5):838-45. PubMed ID: 14990639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weiss criteria in large adrenocortical tumors: a validation study.
    Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
    Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
    Lau SK; Weiss LM
    Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability.
    Blanes A; Diaz-Cano SJ
    Am J Clin Pathol; 2007 Mar; 127(3):398-408. PubMed ID: 17276949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenocortical tumors in children].
    Vallejo D; Queizán A; Carrero MC; Nistal M; Tovar JA
    Cir Pediatr; 1997 Jul; 10(3):122-7. PubMed ID: 9376237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
    Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
    Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adrenocortical tumors with neuroendocrine differentiation].
    Kazantseva IA; Poliakova GA; Gurevich LG; Morozov IA; Bezuglova TV; Smirnov VB
    Arkh Patol; 2002; 64(5):8-13. PubMed ID: 12575533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
    Lü X; Stallmach T; Gebbers JO
    Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
    Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
    Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Adrenocortical Carcinoma.
    Vaidya A; Nehs M; Kilbridge K
    Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
    O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
    J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and caval invasion of left adrenocortical carcinoma.
    Yavascaoglu I; Yilmaz M; Kordan Y
    Urol Int; 2008; 81(2):244-6. PubMed ID: 18758230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined therapy of advanced adrenal cortical adenocarcinoma].
    Xiao ZJ; Li CL
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2123-5. PubMed ID: 21029628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocortical carcinoma: clinical and laboratory observations.
    Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
    Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.